|
Hospice Care
|
N02.421.585.905.400 |
|
|
Terminal Care
|
N02.421.585.905 |
|
|
Maple Syrup Urine Disease
|
C18.452.648.189.520 |
|
|
Acute Kidney Injury
|
C13.351.968.419.780.050 |
|
|
Neurotransmitter Uptake Inhibitors
|
D27.505.519.562.437 |
|
|
Immunoglobulin A, Secretory
|
D12.776.124.486.485.114.619.026.030 |
|
|
Immunoglobulin A
|
D12.776.124.486.485.114.619.026 |
|
|
Caulobacteraceae
|
B03.660.050.090 |
|
|
Optic Atrophy, Autosomal Dominant
|
C18.452.660.665 |
|
|
Secretory Component
|
D12.776.377.715.548.114.619.026.030.500 |
|
|
Immunoglobulin A, Secretory
|
D12.776.377.715.548.114.619.026.030 |
|
|
Granulomatosis, Orofacial
|
C23.550.384 |
|
|
Reverse Transcriptase Inhibitors
|
D27.505.954.122.388.308 |
|
|
Peritoneal Neoplasms
|
C06.301.780 |
|
|
Digestive System Neoplasms
|
C06.301 |
|
|
E-Box Elements
|
G05.360.340.024.340.137.750.249.240 |
|
|
Infarction, Posterior Cerebral Artery
|
C14.907.253.092.477.200.475 |
|
|
Li-Fraumeni Syndrome
|
C16.320.700.600 |
|
|
Neoplastic Syndromes, Hereditary
|
C16.320.700 |
|
|
Lip Neoplasms
|
C07.465.530.550 |
|
